3.Clinical effects of blood purification on the patients with multiple organ dysfunction syndrome.
Xiaojuan YANG ; Shu-Xian WANG ; Yishu LI ; Al ET ;
Chinese Journal of Practical Internal Medicine 2006;0(S1):-
Objective To discuss the effects of blood purification on the patients with multiple organ dysfunction syndrome. Methods Technique of blood purification was applied to the 22 patients with multiple organ dysfunction syndrome. The patients were presented to the Fushun Central Hospital ,between 2003 to 2006. Liver function,kidney function before treatment and after treatment were observed. Results After ttreatment with blood purification,The liver function,kidney function were ameliorated (P
6.The effect of combined application of low dose fentanyl and midazolam on sodium channels in rat cerebral cortical neurons.
Yun-Chun YANG ; Xian ZHOU ; Jia-Li WU ; Xuan JIANG ; Shu-Zhi ZHOU ; Xiao-Bin WANG
Chinese Journal of Applied Physiology 2011;27(1):85-87
Anesthetics, Intravenous
;
administration & dosage
;
pharmacology
;
Animals
;
Animals, Newborn
;
Cerebral Cortex
;
cytology
;
metabolism
;
Drug Synergism
;
Female
;
Fentanyl
;
administration & dosage
;
pharmacology
;
Male
;
Midazolam
;
administration & dosage
;
pharmacology
;
Neurons
;
metabolism
;
Patch-Clamp Techniques
;
Primary Cell Culture
;
Rats
;
Rats, Sprague-Dawley
;
Voltage-Gated Sodium Channels
;
drug effects
7.Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension.
Xian-wei LI ; Yun-xing GAO ; Shu LI ; Jie-ren YANG
China Journal of Chinese Materia Medica 2015;40(7):1355-1361
OBJECTIVETo observe the effect of sesamin (Ses) on pulmonary vascular remodeling in rats with monocrotaline ( MCT)-induced pulmonary hypertension (PH).
METHODTotally 48 male Sprague-Dawley (SD) rats were fed adaptively for one week and then divided into the normal control group, the MCT group, the MCT +Ses (50 mg x kg(-1)) group and the MCT + Ses (100 mg x kg(-1)) group, with 12 rats in each group. The PH rat model was induced through the subcutaneous injection with MCT(60 mg x kg(-1)). After the administration for four weeks, efforts were made to measure the right ventricular systolic pressure( RVSP) and mean pulmonary artery pressure (mPAP) through right jugular vein catheterization, and isolate right ventricle( RV) and left ventricle( LV) +septum (S) and measure their length to calculate RV/ ( LV + S) and ratio of RV to tibial length. Pathologic changes in arterioles were observed by HE staining. Masson's trichrome stain was used to demonstrate changes in collagen deposition of arterioles. The alpha-smooth muscle actin (alpha-SMA) expression in pulmonary arteries was measured by immunohistochemisty. The total antioxidative capacity (T-AOC) and malondialdehyde (MDA) content in pulmonary arteries were determined by the colorimetric method. The protein expressions of collagen I, NOX2 and NOX4 were analyzed by Real-time PCR and Western blot.
RESULTAfter the administration for 4 weeks, Ses could attenuate RVSP and mPAP induced by MCT, RV/ (LV + S) and ratio of RV to Tibial length, alpha-SMA and collagen I expressions and remodeling of pulmonary vessels and right ventricle. Meanwhile, Ses could obviously inhibit the expressions of NOX2, NOX4 and MDA content and increase T-AOC.
CONCLUSIONSesamin could ameliorate pulmonary vascular remodeling induced by monocrotaline in PH rats. Its mechanism may be related to expressions of NOX2 and NOX4 expression and reduction in oxidative stress injury.
Animals ; Dioxoles ; administration & dosage ; Disease Models, Animal ; Drugs, Chinese Herbal ; administration & dosage ; Humans ; Hypertension, Pulmonary ; drug therapy ; enzymology ; genetics ; physiopathology ; Lignans ; administration & dosage ; Lung ; blood supply ; enzymology ; metabolism ; Male ; Membrane Glycoproteins ; genetics ; metabolism ; Monocrotaline ; adverse effects ; NADPH Oxidase 2 ; NADPH Oxidase 4 ; NADPH Oxidases ; genetics ; metabolism ; Pulmonary Artery ; drug effects ; metabolism ; physiopathology ; Rats ; Rats, Sprague-Dawley ; Vascular Remodeling ; drug effects
8.Effect of fibronectin-thrombopoietin gene modification on human bone marrow mesenchymal stem cells.
Lei ZHANG ; Jie YU ; Shu MO ; Guang YANG ; Xin LI ; Ying XIAN ; Xian-qing JIN
Chinese Journal of Hematology 2007;28(12):832-836
OBJECTIVETo observe the effect of Fn-TPO gene modification on human bone marrow mesenchymal stem cells (MSCs).
METHODSRetroviral vector containing Fn-TPO gene was constructed and bone marrow MSCs was modified by this vector. The transcription of Fn-TPO gene in MSCs was observed. The proliferation capacities, hematopoietic cells adhering capacities and TPO secretion capacities of gene modified MSCs were assayed respectively. Cord blood CD34 cells were seeded on the gene modified MSCs layers and several essential growth factors were added. After co-culturing in vitro for 7 days, the number of CD34 cells and their colony forming capacities were assayed by flow cytometry and semisolid culture assay.
RESULTSRetroviral vector containing Fn-TPO gene was successfully constructed and bone marrow MSCs were modified by this vector. Fn-TPO gene was expressed by bone marrow MSCs after gene modification. The viability of MSCs had no significant difference between pre- and post-gene-modification [(7.18 +/- 0.89) 10(4)/ml vs. (6.92 +/- 0.77) 10(4)/ml, P > 0.05]. The hematopoietic cells adhering ability of gene modified bone marrow MSCs was reinforced(0. 188 +/- 0.018 vs. 0.167 +/- 0.017, P < 0.01). The concentration of TPO in the MSCs culture supernatant raised from (5.58 +/- 0.37) ng/ml to (7.46 +/- 0.59) ng/ml (P < 0.01) and did not significantly decline in a short-time period, but influenced by the growth status of MSCs. After co-culturing with gene modified MSCs for 7 days, the absolute number of nucleated cells, the percentage of CD34+ cells and the colony numbers of BFU-E, CFU-GM, CFU-GEMM were (29.9 +/- 2.7) x 10(4), (33.3 +/- 2.8)% , 109.3 +/- 4.1, 163.7 +/- 7.1, 13.3 +/- 1.5, respectively, being significantly higher than that co-cultured with non-modified MSCs.
CONCLUSIONSFn-TPO gene modification can improve the capacity of human bone marrow MSCs for hematopoietic cells adhering, TPO secretion and cord blood CD34 cells amplification.
Bone Marrow Cells ; cytology ; metabolism ; Cell Adhesion ; Cell Proliferation ; Cells, Cultured ; Fibronectins ; genetics ; Gene Fusion ; Genetic Vectors ; Humans ; Mesenchymal Stromal Cells ; cytology ; metabolism ; Retroviridae ; genetics ; Thrombopoietin ; genetics ; metabolism ; Transfection
9.Involvement of PPARs in the regulation of brain CYP2D by growth hormone
ZHANG FU-RONG ; LI JIE ; NA SHU-FANG ; YANG ZHE-QIONG ; XIE XIAN-FEI ; YUE JIANG
Chinese Journal of Pharmacology and Toxicology 2017;31(10):979-980
OBJECTIVE CYP2D is one of the most abundant subfamily of CYPs in the brain, especially in the cerebellum. Brain CYP2D is responsible for the metabolism of endogenous neurotransmitters such as tyramine and serotonin. Our previous studies have shown brain CYP2D can be regulated by exogenous and endogenous substances with tissue- specificity. The purpose of this study is to examine the effects of cerebral CYP2D on the mice behavior and the regulatory mechanism of brain CYP2D by growth hormone. METHODS Mice received the stereotaxic injection with CYP2D inhibitor quinine in deep cerebellar nuclei of cerebellum. The animals were tested with rotarod apparatus, balance beam, water maze, elevated plus maze and open field. The changes in CYP2D22, PPARαand PPARγ in brain regions and liver were assayed in male growth hormone receptor knockout mice, SH-SY5Y cells and HepG2 cells. RESULTS The inhibition of cerebellum CYP2D significantly affected the spatial learning and exploring ability of mice. Compared with WT mice, CYP2D expression was lower in brain regions from GHR(-/- ) male mice; however, hepatic CYP2D level was similar. Pulsatile GH decreased PPARα mRNA level, and increased mRNA levels of CYP2D6 and PPARα in SH- SY5Y cells. In HepG2 cells, pulsatile GH resulted in decreases in PPARα and PPARγ mRNA levels, but not CYP2D6. PPARα inhibitor induced CYP2D6 mRNA and protein by 1.32-fold and 1.43-fold in SH-SY5Y cells. PPARγ inhibitor decreased CYP2D6 mRNA and protein by 74.76% and 40.93%. PPARα agonist decreased the level of CYP2D22 mRNA in liver and cerebellum, while PPARγ agonist rosiglitazone resulted in diametrically increases. The luciferase assay showed that PPARγ actived the CYP2D6 gene promoter while PPARα inhibited its function. Pulsatile GH declined the binding of PPARα with CYP2D6 promoter by 40%, promoted the binding of PPARγ with CYP2D6 promoter by approximate 60%. The levels of brain and liver PPARα expression in male GHR(-/- ) mice is obviously higher than those in WT mice. The level of PPARγ in male GHR(-/- ) mice was decreased in the frontal cortex and hippocampus, while remained stable in the cerebellum and striatum; meanwhile, PPARγ was increased in the liver. CONCLUSION Brain CYP2D may be involved in learning and memory functions of central system. Masculine GH secretion altered the PPARs expression and the binding of PPARs to CYP2D promoter, leading to the elevated brain CYP2D in a tissue- specific manner. Growth hormone may specifically alter the metabolic and synthetic of important endogenous substances in the central nervous system (such as serotonin) through the specific regulation of brain CYP2D expression.
10.Clinical and genetic characteristics of Williams-Beuren syndrome: 2 cases report
qi Shu WANG ; xian Zhi YANG ; Hui LI
Journal of Peking University(Health Sciences) 2017;49(5):899-903
To explore the clinical and genetic characteristics of Williams-Beuren syndrome (WBS) and to raise awareness of the disease.The characteristics of clinical manifestations,personal history,car diac ultrasound,brain magnetic resonance imaging (MRI),electroencephalogram (EEG) and chromosome detection results of two cases with WBS were analyzed.The two patients were both male and the age was 11 months and 1 day,and 9 months and 9 days,respectively.They both suffered from cardiovascular malformation:case one presented supravalvular aortic stenosis,and case two showed atrial septal defect and patent ductus arteriosus.Both of the cases were exhibited characteristic facial features of WBS,including full orbital,spherical nose,fiat nasal bridge,long philtrum and thick lips.For the mental development,case one displayed moderate to severe developmental retardation,and case two showed severe developmental retardation.In addition,case one presented bilateral indirect inguinal hernia and hydrocele,and case two manifested feeding difficulties,buried penis and infantile spasms.Personal history:case one's mother had tocolytic therapy during pregnancy period,and case one was born at full-term by cesarean section due to amniotic fluid pollution.Supplementary examination:brain MRI of the two cases were no significant abnormalities;the EEG of case two showed hypsarrhythmia,and the epileptic spasms were recorded.Chromosome detection results:case one was identified as 7q11.23 deletion including the fragment deletion mutation of elastin (ELN) gene by multiplex ligation dependent probe amplification method,and case two was found with 7q11.21q11.23 deletion by high resolution G-band method.The two cases with WBS both had cardiovascular malformations,special facial features,mental retardation and connective tissue or urinary system abnormality.The supravalvular aortic stenosis of case one may be associated with the deletion of ELN gene,and the occurrence of epilepsy of case two may be related to the q11.21 deletion beyond the 7q11.23 region.